ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2097

Evaluation Of An Advanced Practice Physiotherapist Role in Rheumatology

Chandra Farrer, Rheumatology, Women's College Hospital, Toronto, ON, Canada; Physical Therapy, University of Toronto, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: access to care and physical therapy, Quality Indicators

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ARHP Orthopedics, Low Back Pain and Rehabilitation: Rehabilitation Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Arthritis affects 4.6 million Canadians and is the leading cause of disability in Canada.  Many Canadians do not have access to a family physician. There are currently 353 rheumatologists practicing in Canada. Of these, 44% are 55 and older. The need for arthritis care in Canada, in the context of limited health human resources, has led to evolving models of care. Extended practice roles for physiotherapists, occupational therapists and nurses have been implemented to address access to care and wait times and thereby decrease the burden of illness. Within our setting, the Advanced Practice Physiotherapist role has expanded to ordering x-rays, laboratory tests and more recently to intra-articular joint injections of the knee and shoulder. The purpose of this study is to evaluate the impact of the Advanced Practice Physiotherapist role in Rheumatology clinics.

Methods: Patient Volumes, wait times, and diagnosis information was  collected from April 2009 using patient service information. Volumes of patients, seen by the Advanced Practice Physiotherapist,  requiring x-ray, laboratory tests and intra-articular joint injection were also collected. Patient satisfaction was collected from April 2009-Sept 2009 on consecutive patients.

Results: The Advanced Practice Physiotherapist had 1711 total patient visits. Wait times in the clinic have trended downward, while overall clinic volumes have remained stable. Diagnosis classification are: Osteoarthritis (40.33%), Inflammatory Arthritis (37.58%), non-articular rheumatism (14.32%), other (4.32%) and chronic pain (3.51%).Patient’s reported being “extremely satisfied” or “very satisfied” with the Advanced Practice Physiotherapist skills/knowledge, recommendations for care, explanation of assessment results and answers given to questions. Intra-articular joint injections have been required for 7.89% of visits, laboratory tests 23.38% of visits and x-rays 16.19% of visits.

Conclusion: The Advanced Practice Physiotherapist role has evolved since April 2009 by gradually expanding the scope of practice to ordering x-rays, laboratory tests and more recently intra-articular joint injections. There has been a positive trend towards decreasing wait times while maintaining overall Rheumatology clinic volumes. Patient satisfaction with the role has been high.  Further research is needed to demonstrate efficacy of intra-articular joint injections performed by the advanced practice physiotherapist as this is a new endeavour for our clinic. Cost effectiveness and efficiency of the model need to be addressed in future.


Disclosure:

C. Farrer,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-an-advanced-practice-physiotherapist-role-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology